VNRX-7145

DRUG4 trials

Sponsors

Basilea Pharmaceutica

Conditions

Healthy SubjectsHealthy VolunteersPharmacokinetics

Phase 1

VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers

CompletedNCT04243863

Basilea PharmaceuticaHealthy Volunteers

Start: 2020-01-20End: 2021-04-05Updated: 2025-12-03

VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers

CompletedNCT04877379

Basilea PharmaceuticaHealthy Subjects

Start: 2021-06-08End: 2021-11-10Updated: 2025-12-08

Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function

CompletedNCT05488678

Basilea PharmaceuticaPharmacokinetics

Start: 2022-10-12End: 2023-11-23Updated: 2025-12-08

Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants

CompletedNCT05527834

Basilea PharmaceuticaPharmacokinetics

Start: 2022-09-13End: 2023-02-10Updated: 2025-12-08

Related Papers

Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers

Antimicrobial Agents and Chemotherapy2025-08-14